Aurinia Pharmaceuticals (AUPH) stock Forecast for 2022 – 2026
Last update: November 26, 2022 (16:46)Sector: Healthcare
The share price of Aurinia Pharmaceuticals Inc. (AUPH) now
What analysts predict: $11.71
52-week high/low: $24.45 / $4.57
50/200 Day Moving Average: $6.93 / $10.12
This figure corresponds to the average price over the previous 50/200 days. For Aurinia Pharmaceuticals stocks, the 50-day moving average is the resistance level today.
For Aurinia Pharmaceuticals stocks, the 200-day moving average is the resistance level today.
Are you interested in Aurinia Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aurinia Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one Aurinia Pharmaceuticals share be worth in 2022 - 2026?
When should I take profit in Aurinia Pharmaceuticals stock? When should I record a loss on Aurinia Pharmaceuticals stock? What are analysts' forecasts for Aurinia Pharmaceuticals stock? What is the future of Aurinia Pharmaceuticals stock? We forecast Aurinia Pharmaceuticals stock performance using neural networks based on historical data on Aurinia Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Aurinia Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aurinia Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Aurinia Pharmaceuticals stock
The chart below shows the historical price of Aurinia Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aurinia Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Aurinia Pharmaceuticals daily forecast for a month
Aurinia Pharmaceuticals Daily Price Targets
Aurinia Pharmaceuticals Stock Forecast 11-28-2022.
Forecast target price for 11-28-2022: $5.35.
Positive dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 6.352%.
Pessimistic target level: 5.21
Optimistic target level: 5.56
Aurinia Pharmaceuticals Stock Forecast 11-29-2022.
Forecast target price for 11-29-2022: $5.41.
Positive dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 5.486%.
Pessimistic target level: 5.32
Optimistic target level: 5.63
Aurinia Pharmaceuticals Stock Forecast 11-30-2022.
Forecast target price for 11-30-2022: $5.13.
Negative dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 6.299%.
Pessimistic target level: 4.90
Optimistic target level: 5.23
Aurinia Pharmaceuticals Stock Forecast 12-01-2022.
Forecast target price for 12-01-2022: $5.08.
Negative dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 7.916%.
Pessimistic target level: 4.85
Optimistic target level: 5.27
Aurinia Pharmaceuticals Stock Forecast 12-02-2022.
Forecast target price for 12-02-2022: $5.33.
Positive dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 8.827%.
Pessimistic target level: 5.08
Optimistic target level: 5.58
Aurinia Pharmaceuticals Stock Forecast 12-03-2022.
Forecast target price for 12-03-2022: $5.59.
Positive dynamics for Aurinia Pharmaceuticals shares will prevail with possible volatility of 4.372%.
Pessimistic target level: 5.43
Optimistic target level: 5.68
AUPH (AUPH) Monthly Stock Prediction for 2022
Aurinia Pharmaceuticals forecast for this year
Aurinia Pharmaceuticals Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $4.3792. Pessimistic: $4.07. Optimistic: $4.79
Aurinia Pharmaceuticals (AUPH) Monthly Stock Prediction for 2023
Aurinia Pharmaceuticals (AUPH) Monthly Stock Prediction for 2024
Aurinia Pharmaceuticals (AUPH) Monthly Stock Prediction for 2025
Aurinia Pharmaceuticals (AUPH) Monthly Stock Prediction for 2026
Aurinia Pharmaceuticals information and performance
Aurinia Pharmaceuticals Inc. is a late stage clinical biopharmaceutical company. The company focuses on the development and commercialization of treatments for target groups of patients with serious illnesses. Voklosporin develops for several indications. Voclosporine is an exploratory therapy. He is developing voklosporin for the treatment of lupus nephritis (LN) and other proteinuric diseases. He also puts forward the solution of Voclosporin Ophthalmic (VOC), a topical formation, for the treatment of dry eye syndrome (DES). Voclosporin is a calcineurin inhibitor (CNI). By inhibiting calcineurin, voclosporin blocks IL-2 expression and T-cell mediated immune responses and stabilizes the podocyte in the kidney.
#1203-4464 MARKHAM STREET, VICTORIA BC, BC, CA
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.